Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Anagenics Limited ( (AU:AN1) ) has provided an update.
Anagenics Limited has reported its quarterly activities for the period ending December 31, 2024, highlighting the impact of its restructuring efforts. The company achieved a significant reduction in its operating cash outflow to $0.3 million from $0.9 million in the previous quarter, despite reduced revenues following the divestment of Face Medi. This improvement was largely due to decreased payments to suppliers and employees, with notable cost reductions in advertising, marketing, staff, and corporate expenses. The company anticipates realizing the full benefits of the restructure in the next quarter, while efforts to reinstate its securities to quotation are ongoing.
More about Anagenics Limited
Anagenics Limited is a health, beauty, and wellness company focused on enhancing shareholder value through the global distribution and sales of its proprietary and licensed anti-aging solutions. It operates primarily through its wholly owned subsidiary, BLC Cosmetics Pty Ltd, which specializes in the sales and distribution of Australian and international cosmetic and wellness brands.
Current Market Cap: A$3.69M
For detailed information about AN1 stock, go to TipRanks’ Stock Analysis page.
